You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Percutaneous Transluminal Coronary Intervention

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FFR Guided Percutaneous Coronary Intervention in Coronary Tandem

Recruiting
  • Percutaneous Transluminal Coronary Angioplasty
  • 5 year Follow-up
  • Seoul, Songpa-gu, Korea, Republic of
  • +13 more
Dec 12, 2022

Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Percutaneous Transluminal Coronary Angioplasty Trial

Withdrawn
  • Coronary Artery Disease
  • +2 more
  • Chronic Total Occlusion Percutaneous Coronary Intervention
  • Sham Procedure
  • (no location specified)
Jun 2, 2021

The INVADER™ Percutaneous Transluminal Coronary Angioplasty Post

Completed
  • Coronary Artery Disease
  • +2 more
  • INVADER™ PTCA Balloon Dilatation Catheter
  • Istanbul, Turkey
    Alvimedica
Jun 13, 2023

Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™

Active, not recruiting
  • Ischemic Heart Disease
  • +4 more
  • Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
  • Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
  • Shenyang, Liaoning, China
  • +1 more
Nov 2, 2022

Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • Coronary Artery Disease
  • (no location specified)
Oct 22, 2023

Coronary Artery Disease, Drug Coated-balloon, Intravascular Ultrasound Trial in Valencia (Drug coated-balloon percutaneous

Recruiting
  • Coronary Artery Disease
  • +5 more
  • Drug coated-balloon percutaneous coronary intervention.
  • Angiography-derived coronary physiology (IMRangio)
  • Valencia, Spain
    Hospital Universitario y Politécnico La Fe
Oct 8, 2023

High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary Trial (VITALYST System)

Not yet recruiting
  • High-risk Percutaneous Coronary Intervention
  • Heart Disease, Coronary
  • VITALYST System
  • (no location specified)
Nov 9, 2023

Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Percutaneous coronary intervention)

Recruiting
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • Percutaneous coronary intervention
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 15, 2022

Coronary Artery Disease Trial in Toulouse (GUIDEX® guiding catheter, Launcher™ coronary guide catheter)

Not yet recruiting
  • Coronary Artery Disease
  • GUIDEX® guiding catheter
  • Launcher™ coronary guide catheter
  • Toulouse, France
    CHU Toulouse
Aug 22, 2023

Characterize REAL-WORLD EVIDENCE Regarding Safety and

Recruiting
  • Coronary Artery Stenosis
  • Percutaneous Transluminal Coronary Angioplasty
  • La Rochelle, France
    Hôpital Saint Louis
Sep 7, 2022

Laboratory Indices to Left Ventricular Thrombus Formation in

Not yet recruiting
  • Left Ventricular Thrombus
  • Primary percutaneous coronary intervention or thrombolytic therapy
  • (no location specified)
Nov 29, 2023

Percutaneous Coronary Intervention Versus Coronary Artery Bypass

Enrolling by invitation
  • Coronary Stenosis
  • Coronary Artery Disease
  • percutaneous coronary intervention vs bypass graft surgery
  • Bad Krozingen, Baden Würtemberg, Germany
  • +3 more
Jul 19, 2023

Percutaneous Coronary Intervention Trial in Seoul

Not yet recruiting
  • Percutaneous Coronary Intervention
    • Seoul, Korea, Republic of
    • +1 more
    Aug 1, 2023

    Patients Undergoing Percutaneous Coronary Intervention

    Recruiting
    • Acute Coronary Syndrome
    • +3 more
      • Jinan, Shandong, China
        Jinan Central Hospital
      Jan 31, 2023

      Coronary Artery Stenosis Trial in Seoul (State-of-the-Art Percutaneous Coronary Intervention, standard CABG)

      Not yet recruiting
      • Coronary Artery Stenosis
      • State-of-the-Art Percutaneous Coronary Intervention
      • standard CABG
      • Seoul, Korea, Republic of
        Asan Medical Center
      Apr 14, 2023

      Coronary Artery Disease Trial in Ho Chi Minh City (Percutaneous Coronary Intervention)

      Recruiting
      • Coronary Artery Disease
      • Percutaneous Coronary Intervention
      • Ho Chi Minh City, Vietnam
        University Medical Center
      Oct 1, 2023

      Bleeding and Ischemic Risk

      Completed
      • Coronary Artery Disease
      • Percutaneous Coronary Intervention
      • Percutaneous coronary intervention
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Oct 13, 2023

      Urinary Retention Trial in Istanbul (Modified Supine Position)

      Not yet recruiting
      • Urinary Retention
      • Modified Supine Position
      • Istanbul, Turkey
        Basaksehir Cam ve Sakura City Hospital
      Sep 30, 2023

      Coronary Artery Disease Trial in Ferrara, Naples (Cangrelor 50 MG)

      Not yet recruiting
      • Coronary Artery Disease
      • Cangrelor 50 MG
      • Ferrara, Italy
      • +1 more
      Oct 13, 2023

      Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,

      Not yet recruiting
      • Acute Coronary Syndrome
      • Non ST Segment Elevation Acute Coronary Syndrome
      • (no location specified)
      Oct 20, 2023

      Coronary Artery Disease, Atherosclerosis Trial in Seoul (Percutaneous coronary intervention for complex lesion, Drug-eluting

      Completed
      • Coronary Artery Disease
      • Atherosclerosis
      • Percutaneous coronary intervention for complex lesion
      • +3 more
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jan 16, 2023

      Obesity Associated Disorder, Myocardial Infarction Trial in Suwon (Percutaneous coronary intervention (PCI), Coronary artery

      Active, not recruiting
      • Obesity Associated Disorder
      • Myocardial Infarction
      • Percutaneous coronary intervention (PCI)
      • Coronary artery bypass grafting (CABG)
      • Suwon, Gyeong-gido, Korea, Republic of
        Ajou University School of Medicine
      Dec 11, 2022

      Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Wuhan (Colchicine 0.5 MG, Colchicine 0.375 MG, Colchicine

      Not yet recruiting
      • Coronary Artery Disease
      • Percutaneous Coronary Intervention
      • Colchicine 0.5 MG
      • +3 more
      • Wuhan, Hubei, China
        Department of Cardiology, Union Hospital, Tongji Medical College
      Oct 5, 2023

      Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)

      Active, not recruiting
      • Coronary Microvascular Dysfunction
      • Beijing, Beijing, China
        Peking university first hospital
      Aug 1, 2023

      Coronary Artery Disease Trial (Routine Angiography Follow-up, Routine Clinical Follow-up)

      Not yet recruiting
      • Coronary Artery Disease
      • Routine Angiography Follow-up
      • Routine Clinical Follow-up
      • (no location specified)
      Jun 20, 2023